Novadaq Technologies Inc.
TSX : NDQ

Novadaq Technologies Inc.

July 31, 2007 07:00 ET

Novadaq Announces Second Quarter 2007 Conference Call and Webcast

TORONTO, ONTARIO--(Marketwire - July 31, 2007) -

Attention Business Editors:

Novadaq® Technologies Inc. (TSX:NDQ), a developer of real-time medical
imaging systems and image guided therapies for the operating room, will
host a conference call and live webcast to discuss the financial results
for the second quarter ended June 30, 2007.



Date: August 7, 2007

Time: 4:30 pm, Eastern Time

Dial in number: 416-644-3425 or 1-800-590-1508

Taped replay: 416-640-1917 or 1-877-289-8525 (Available until
August 14th, 2007)

Code number: 21241897

Webcast: A live audio webcast of the call will be available at
www.novadaq.com
Please connect to this website at least 15 minutes
prior to the conference call to ensure adequate time
for any software download that may be needed to hear
the webcast. The webcast will be archived for 90 days.


About Novadaq Technologies

Novadaq Technologies Inc. (TSX:NDQ) develops and commercializes medical
imaging systems and real-time image guided therapies for use in the operating
room. Novadaq's proprietary imaging platform can be used to visualize blood
vessels, nerves and the lymphatic system during surgical procedures. Novadaq's
SPY® Imaging System, commercially available worldwide, enables cardiac
surgeons to visually assess coronary vasculature and bypass graft
functionality during the course of open-heart surgery. Novadaq's OPTTX®
System which received CE Mark approval in November 2006, is aimed at the
diagnosis, evaluation and treatment of wet Age-related Macular Degeneration
(AMD) by using the same core imaging technology that is used in the SPY
Imaging System. The HELIOS™ Imaging System, which received FDA clearance in
January 2007, is the first fluorescent imaging system available for use during
plastic reconstructive surgery allowing surgeons to evaluate pre- and
intra-operative blood flow, as well as post-surgery perfusion. Novadaq's
LUNA™ Imaging System is designed to enable surgeons to visualize nerve
bundles during the course of urological and neurological procedures. LUNA has
been granted a license for use by Health Canada. Novadaq is also the exclusive
United States distributor of PLC Medical's CO(2) HEART LASER™ System for
TMR (Trans-Myocardial Revascularization). Novadaq recently acquired a
comprehensive portfolio of minimally invasive native tissue fluorescence
imaging technology with the vision to expand the applications for this
technology in Novadaq's surgical markets. For more information, please visit
the company's website at www.novadaq.com.

Certain statements included in this press release may be considered
forward-looking. Such statements involve known and unknown risks,
uncertainties and other factors that may cause actual results, performance or
achievements to be materially different from those implied by such statements,
and therefore these statements should not be read as guarantees of future
performance or results. All forward-looking statements are based on Novadaq's
current beliefs as well as assumptions made by and information currently
available to Novadaq and relate to, among other things, anticipated financial
performance, business prospects, strategies, regulatory developments, market
acceptance and future commitments, including (among other matters) that
Novadaq will complete its proposed private placement on the basis described
herein or at all. Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this press
release. Due to risks and uncertainties, including the risks and uncertainties
identified by Novadaq in its public securities filings; actual events may
differ materially from current expectations. Novadaq disclaims any intention
or obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.

For further information: visit our website at www.novadaq.com.

Contact Information